APA (7th ed.) Citation

Ismail, A., Modi, M., Kleckley, A., Midhun, M., Basu, A., Jahan, N., . . . Desai, A. (2024). 172P HER2 expression across solid tumors and real-world implications for use of fam-trastuzumab deruxtecan-nxki (T-Dxd). Annals of Oncology, 35, S284. https://doi.org/10.1016/j.annonc.2024.08.2177

Chicago Style (17th ed.) Citation

Ismail, A., et al. "172P HER2 Expression Across Solid Tumors and Real-world Implications for Use of Fam-trastuzumab Deruxtecan-nxki (T-Dxd)." Annals of Oncology 35 (2024): S284. https://doi.org/10.1016/j.annonc.2024.08.2177.

MLA (9th ed.) Citation

Ismail, A., et al. "172P HER2 Expression Across Solid Tumors and Real-world Implications for Use of Fam-trastuzumab Deruxtecan-nxki (T-Dxd)." Annals of Oncology, vol. 35, 2024, p. S284, https://doi.org/10.1016/j.annonc.2024.08.2177.